2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy

RR Makkar, P Blanke, J Leipsic, V Thourani… - Journal of the American …, 2020 - jacc.org
Background Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet
thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed …

Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes

M Fukui, VN Bapat, S Garcia, MW Dworak… - Circulation, 2022 - Am Heart Assoc
Background: Although transcatheter aortic valve replacement (TAVR) therapy continues to
grow, there have been concerns about the occurrence of hypoattenuating leaflet thickening …

5-year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial

M Abdel-Wahab, M Landt, FJ Neumann… - Cardiovascular …, 2020 - jacc.org
Objectives The purpose of this study was to evaluate clinical and echocardiographic
outcome data of the CHOICE (Randomized Comparison of Transcatheter Heart Valves in …

Native aortic valve disease progression and bioprosthetic valve degeneration in patients with transcatheter aortic valve implantation

J Kwiecinski, E Tzolos, TRG Cartlidge, A Fletcher… - Circulation, 2021 - Am Heart Assoc
Background: Major uncertainties remain regarding disease activity within the retained native
aortic valve, and regarding bioprosthetic valve durability, after transcatheter aortic valve …

Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal …

K Korsholm, JM Jensen, BL Nørgaard… - Circulation …, 2019 - Am Heart Assoc
Background: Device-related thrombosis (DRT) following left atrial appendage occlusion is a
rare but feared complication. The diagnostic value of cardiac compute tomography (CT) for …

Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association

GR Shroff, S Bangalore, NM Bhave, TI Chang… - Circulation, 2021 - Am Heart Assoc
Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …

Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes

Y Xue, AP Kossar, A Abramov, A Frasca… - Cardiovascular …, 2023 - academic.oup.com
Abstract Aims Bioprosthetic heart valves (BHVs), made from glutaraldehyde-fixed heterograft
materials, are subject to more rapid structural valve degeneration (SVD) in paediatric and …

Noncalcific mechanisms of bioprosthetic structural valve degeneration

M Marro, AP Kossar, Y Xue, A Frasca… - Journal of the …, 2021 - Am Heart Assoc
Bioprosthetic heart valves (BHVs) largely circumvent the need for long‐term anticoagulation
compared with mechanical valves but are increasingly susceptible to deterioration and …